{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T01:00:12Z","timestamp":1787792412235,"version":"build-2784847793"},"reference-count":63,"publisher":"American Chemical Society (ACS)","issue":"17","license":[{"start":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T00:00:00Z","timestamp":1756166400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>We report the regioselective chemical derivatization of (R)-2-((4-aminophenethyl)amino)-1-phenylethan-1-ol, the primary metabolite of the \u03b23-Adrenergic Receptor (\u03b23-AR) agonist mirabegron, with prototypical Carbonic Anhydrase Inhibitors (CAIs) to afford the carbamates 10\u201314 and the ureido derivatives 15\u201318. Such compounds were endowed in vitro with distinct inhibition profiles for the human (h) Carbonic Anhydrases (CAs) and showed preferential agonisms for the \u03b23-AR subtype. Among them, 14 induced remarkable intraocular pressure (IOP) lowering in an in vivo transient model of ocular hypertension, with the maximal effect at 120 min post-administration at 1% w\/v concentration. Furthermore, the high stability of the compounds in rabbit plasma and their ability to induce full vasodilation in isolated porcine retinal arteries suggested that the observed in vivo effects likely result from a combination of conventional aqueous humor reduction and modulation of ocular vascular tone, both of which are mediated by CAs and \u03b2-ARs. The pronounced melanosomal accumulation of representative compounds 14 and 16 highlights their potential as ideal candidates for evaluating pharmacokinetic profiles in ophthalmic applications. The results of this study provide strong evidence for the biomedical repurposing of a neglected metabolite through a novel class of dual-targeting ligands, also offering a promising strategy to help counteract the ongoing decline in drug discovery.<\/jats:p>","DOI":"10.1021\/acs.jmedchem.5c01459","type":"journal-article","created":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T15:49:17Z","timestamp":1756223357000},"page":"18579-18596","source":"Crossref","is-referenced-by-count":5,"title":["Repurposing Drug Metabolites into Dual \u03b2-Adrenergic Receptor\u2013Carbonic Anhydrase Modulators as Potential Tools for Ocular Disorders"],"prefix":"10.1021","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7364-1499","authenticated-orcid":true,"given":"Andrea","family":"Ammara","sequence":"first","affiliation":[{"name":"University of Florence , , Via Ugo Schiff 6 , Sesto Fiorentino, ,","place":["Florence, Italy, 50019"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Carone","sequence":"additional","affiliation":[{"name":"University of Florence , , Via Ugo Schiff 6 , Sesto Fiorentino, ,","place":["Florence, Italy, 50019"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Lucarini","sequence":"additional","affiliation":[{"name":"University of Florence , , Viale Gaetano Pieraccini, 6 , ,","place":["Florence, Italy, 50139"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Sgambellone","sequence":"additional","affiliation":[{"name":"University of Florence , , Viale Gaetano Pieraccini, 6 , ,","place":["Florence, Italy, 50139"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Marri","sequence":"additional","affiliation":[{"name":"University of Florence , , Viale Gaetano Pieraccini, 6 , ,","place":["Florence, Italy, 50139"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serafina","family":"Villano","sequence":"additional","affiliation":[{"name":"University of Florence , , Viale Gaetano Pieraccini, 6 , ,","place":["Florence, Italy, 50139"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosanna","family":"Matucci","sequence":"additional","affiliation":[{"name":"University of Florence , , Viale Gaetano Pieraccini, 6 , ,","place":["Florence, Italy, 50139"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerta","family":"Luga","sequence":"additional","affiliation":[{"name":"University of Florence , , Viale Gaetano Pieraccini, 6 , ,","place":["Florence, Italy, 50139"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Fittipaldi","sequence":"additional","affiliation":[{"name":"University of Florence , , Viale Gaetano Pieraccini, 6 , ,","place":["Florence, Italy, 50139"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9052-4075","authenticated-orcid":true,"given":"Riccardo","family":"Pecori","sequence":"additional","affiliation":[{"name":"German Cancer Research Center (DKFZ) , Im Neuenheimer Feld 280 , ,","place":["Heidelberg, Germany, 69120"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Pieraccini","sequence":"additional","affiliation":[{"name":"University of Florence , , Viale Gaetano Pieraccini 6 , ,","place":["Florence, Italy, 50139"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Di Serio","sequence":"additional","affiliation":[{"name":"University of Florence, Azienda Ospedaliera Universitaria Careggi , , Viale Gaetano Pieraccini 6 , ,","place":["Florence, Italy, 50139"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8137-1513","authenticated-orcid":true,"given":"Andrea","family":"Garci\u0301a-Llorca","sequence":"additional","affiliation":[{"name":"University of Iceland , , ,","place":["Reykjavi\u0301k, Iceland, 101"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thor","family":"Eysteinsson","sequence":"additional","affiliation":[{"name":"University of Iceland , , ,","place":["Reykjavi\u0301k, Iceland, 101"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanislav","family":"Kalinin","sequence":"additional","affiliation":[{"name":"University of Eastern Finland , , Yliopistonrinne 3 , ,","place":["Kuopio, Finland, 70211"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-6627-7251","authenticated-orcid":true,"given":"Julius Aleksi Olavi","family":"Viita","sequence":"additional","affiliation":[{"name":"University of Eastern Finland , , Yliopistonrinne 3 , ,","place":["Kuopio, Finland, 70211"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arto","family":"Urtti","sequence":"additional","affiliation":[{"name":"University of Eastern Finland , , Yliopistonrinne 3 , ,","place":["Kuopio, Finland, 70211"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1141-6146","authenticated-orcid":true,"given":"Fabrizio","family":"Carta","sequence":"additional","affiliation":[{"name":"University of Florence , , Via Ugo Schiff 6 , Sesto Fiorentino, ,","place":["Florence, Italy, 50019"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Selleri","sequence":"additional","affiliation":[{"name":"University of Florence , , Via Ugo Schiff 6 , Sesto Fiorentino, ,","place":["Florence, Italy, 50019"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4262-0323","authenticated-orcid":true,"given":"Claudiu T.","family":"Supuran","sequence":"additional","affiliation":[{"name":"University of Florence , , Via Ugo Schiff 6 , Sesto Fiorentino, ,","place":["Florence, Italy, 50019"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2025,8,26]]},"reference":[{"key":"2026073102125945300_cit1","volume-title":"Antimicrobial\nresistance"},{"key":"2026073102125945300_cit2","volume-title":"Antimicrobial\nresistance remains a health threat in Europe","author":"WHO and ECDC report."},{"key":"2026073102125945300_cit3","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.3390\/cancers6031769","article-title":"Drug resistance in cancer: An overview","volume":"3","author":"Housman","year":"2014","journal-title":"Cancers"},{"key":"2026073102125945300_cit4","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/s1368-7646(03)00059-1","article-title":"Drug resistance and the microenvironment:\nnature and nurture","volume":"4","author":"Morin","year":"2003","journal-title":"Drug Resist. Update"},{"key":"2026073102125945300_cit5","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/s41586-019-1730-1","article-title":"A view\non drug resistance in cancer","volume":"575","author":"Vasan","year":"2019","journal-title":"Nature"},{"key":"2026073102125945300_cit6","doi-asserted-by":"publisher","first-page":"3402","DOI":"10.1038\/s41467-023-38507-4","article-title":"Efflux pump\ngene amplifications bypass necessity of multiple target mutations\nfor resistance against dual-targeting antibiotic","volume":"1","author":"Silva","year":"2023","journal-title":"Nat. Commun."},{"key":"2026073102125945300_cit7","doi-asserted-by":"publisher","first-page":"8826","DOI":"10.1038\/s41598-023-35256-8","article-title":"Effects\nof the order of exposure to antimicrobials on the incidence of multidrug-resistant\nPseudomonas aeruginosa","volume":"1","author":"Yasuda","year":"2023","journal-title":"Sci. Rep."},{"key":"2026073102125945300_cit8","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1038\/nrd3405","article-title":"The productivity\ncrisis in pharmaceutical R&D","volume":"10","author":"Pammolli","year":"2011","journal-title":"Nat. Rev.\nDrug Discovery"},{"key":"2026073102125945300_cit9","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/nrd4609","article-title":"An analysis of the attrition of drug candidates from\nfour major pharmaceutical companies","volume":"14","author":"Waring","year":"2015","journal-title":"Nat. Rev.\nDrug Discovery"},{"key":"2026073102125945300_cit10","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/nrd3681","article-title":"Diagnosing the decline in pharmaceutical\nR&D efficiency","volume":"11","author":"Scannell","year":"2012","journal-title":"Nat. Rev. Drug Discovery"},{"key":"2026073102125945300_cit11","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1038\/d41573-020-00059-3","article-title":"Breaking Eroom\u2019s\nLaw","volume":"19","author":"Ringel","year":"2020","journal-title":"Nat. Rev. Drug Discovery"},{"key":"2026073102125945300_cit12","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/nrd1468","article-title":"Drug repositioning: identifying and\ndeveloping new uses for existing drugs","volume":"3","author":"Ashburn","year":"2004","journal-title":"Nat.\nRev. Drug Discovery"},{"key":"2026073102125945300_cit13","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nrd.2018.168","article-title":"Drug repurposing: progress,\nchallenges and recommendations","volume":"18","author":"Pushpakom","year":"2019","journal-title":"Nat. Rev. Drug\nDiscovery"},{"key":"2026073102125945300_cit14","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s40261-013-0084-y","article-title":"Role of cytochrome p450\nisoenzymes 3A and 2D6 in the in vivo metabolism of mirabegron, a \u03b23-adrenoceptor\nagonist","volume":"33","author":"Lee","year":"2013","journal-title":"Clin. Drug Investig."},{"key":"2026073102125945300_cit15","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1124\/dmd.111.043588","article-title":"Absorption,\nmetabolism and excretion of [(14)C]mirabegron (YM178), a potent and\nselective \u03b2(3)-adrenoceptor agonist, after oral administration\nto healthy male volunteers","volume":"4","author":"Takusagawa","year":"2012","journal-title":"Drug Metab. Dispos."},{"key":"2026073102125945300_cit16","article-title":"Drugs@FDA: FDA-Approved Drugs"},{"key":"2026073102125945300_cit17","unstructured":"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2012\/202611Orig1s000Approv.pdf. Access 13 May 2025."},{"key":"2026073102125945300_cit18","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/sj.tpj.6500393","article-title":"Pharmacogenetics\nof the human beta-adrenergic receptors","volume":"7","author":"Taylor","year":"2007","journal-title":"Pharmacogenomics\nJ."},{"key":"2026073102125945300_cit19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/s0014-2999(02)01728-4","article-title":"Beta-adrenoceptor agonists and asthma\u2013100\nyears of development","volume":"445","author":"Waldeck","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"2026073102125945300_cit20","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1111\/j.1476-5381.1973.tb08232.x","article-title":"Some observations\non the \u03b2-adrenoceptor agonist properties of the isomers of salbutamol","volume":"48","author":"Brittain","year":"1973","journal-title":"Br. J. Pharmacol."},{"key":"2026073102125945300_cit21","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1007\/s00059-002-2434-z","article-title":"The beta-adrenergic receptors","volume":"27","author":"Wallukat","year":"2002","journal-title":"Herz"},{"key":"2026073102125945300_cit22","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1159\/000339271","article-title":"Beta-Adrenergic\nReceptors, from Their Discovery and Characterization through Their\nManipulation to Beneficial Clinical Application","volume":"122","author":"Wachter","year":"2012","journal-title":"Cardiology"},{"key":"2026073102125945300_cit23","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/nrd.2017.178","article-title":"Trends in GPCR drug discovery: new\nagents, targets and indications","volume":"16","author":"Hauser","year":"2017","journal-title":"Nat. Rev. Drug\nDiscovery"},{"key":"2026073102125945300_cit24","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.cell.2017.07.009","article-title":"How ligands illuminate GPCR molecular\npharmacology","volume":"170","author":"Wacker","year":"2017","journal-title":"Cell"},{"key":"2026073102125945300_cit25","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1111\/j.1476-5381.2009.00602.x","article-title":"Ligand-directed signalling at beta-adrenoceptors","volume":"159","author":"Evans","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"2026073102125945300_cit26","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.str.2020.01.001","article-title":"Biased signaling of the G-protein-coupled receptor\n\u03b22AR is governed by conformational exchange kinetics","volume":"28","author":"Lamichhane","year":"2020","journal-title":"Structure"},{"key":"2026073102125945300_cit27","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3390\/ijms23010461","article-title":"Aromatic Sulfonamides including a Sulfonic Acid Tail:\nNew Membrane Impermeant Carbonic Anhydrase Inhibitors for Targeting\nSelectively the Cancer-Associated Isoforms","volume":"23","author":"Giovannuzzi","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"2026073102125945300_cit28","doi-asserted-by":"publisher","first-page":"3475","DOI":"10.1016\/j.bmcl.2008.05.051","article-title":"Carbonic\nanhydrase inhibitors: design of spin-labeled sulfonamides incorporating\nTEMPO moieties as probes for cytosolic or transmembrane isozymes","volume":"18","author":"Cecchi","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"2026073102125945300_cit29","doi-asserted-by":"publisher","first-page":"5081","DOI":"10.1016\/j.bmc.2010.05.072","article-title":"Pteridine-sulfonamide conjugates\nas dual inhibitors of carbonic anhydrases and dihydrofolate reductase\nwith potential antitumor activity","volume":"18","author":"Marques","year":"2010","journal-title":"Bioorg. Med.\nChem."},{"key":"2026073102125945300_cit30","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1021\/acs.jmedchem.6b01607","article-title":"Design and Synthesis\nof Novel Nonsteroidal Anti-Inflammatory Drugs and Carbonic Anhydrase\nInhibitors Hybrids (NSAIDs-CAIs) for the Treatment of Rheumatoid Arthritis","volume":"3","author":"Bua","year":"2017","journal-title":"J. Med. Chem."},{"key":"2026073102125945300_cit31","unstructured":"http:\/\/isyn.luoszgroup.com\/. Access 13 May 2025."},{"key":"2026073102125945300_cit32","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1002\/anie.199409381","article-title":"Scales of Nucleophilicity\nand Electrophilicity: A System for Ordering Polar Organic and Organometallic\nReactions","volume":"33","author":"Mayr","year":"1994","journal-title":"Angew. Chem., Int. Ed."},{"key":"2026073102125945300_cit33","doi-asserted-by":"publisher","first-page":"9500","DOI":"10.1021\/ja010890y","article-title":"Reference scales for the characterization of cationic\nelectrophiles and neutral nucleophiles","volume":"123","author":"Mayr","year":"2001","journal-title":"J. Am.\nChem. Soc."},{"key":"2026073102125945300_cit34","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1021\/ar020094c","article-title":"Pi-nucleophilicity\nin carbon-carbon bond-forming reactions","volume":"36","author":"Mayr","year":"2003","journal-title":"Acc.\nChem. Res."},{"key":"2026073102125945300_cit35","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.1016\/S0021-9258(18)62326-9","article-title":"The carbon dioxide hydration\nactivity of carbonic anhydrase. I. Stop-flow kinetic studies on the\nnative human isoenzymes B and C","volume":"246","author":"Khalifah","year":"1971","journal-title":"J. Biol. Chem."},{"key":"2026073102125945300_cit36","doi-asserted-by":"publisher","first-page":"5380","DOI":"10.1021\/acs.jmedchem.8b00625","article-title":"Discovery\nof \u03b2-Adrenergic Receptors Blocker-Carbonic Anhydrase Inhibitor\nHybrids for Multitargeted Antiglaucoma Therapy","volume":"61","author":"Nocentini","year":"2018","journal-title":"J. Med. Chem."},{"key":"2026073102125945300_cit37","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s00210-006-0104-z","article-title":"Comparison of three radioligands\nfor the labelling of human beta-adrenoceptor subtypes","volume":"374","author":"Niclauss","year":"2006","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"2026073102125945300_cit38","doi-asserted-by":"publisher","first-page":"70","DOI":"10.2174\/187231209788654081","article-title":"Esterase Activities\nin the Blood, Liver and Intestine of Several Preclinical Species and\nHumans","volume":"3","author":"Berry","year":"2009","journal-title":"Drug Metab. Lett."},{"key":"2026073102125945300_cit39","doi-asserted-by":"publisher","first-page":"3979","DOI":"10.1002\/jps.23258","article-title":"Species Difference of Esterase Expression and Hydrolase Activity\nin Plasma","volume":"101","author":"Bahar","year":"2012","journal-title":"J. Pharm. Sci."},{"key":"2026073102125945300_cit40","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1007\/BF00785664","article-title":"Esterase\nActivity of the Blood of Various Animal Species","volume":"55","author":"Filov","year":"1964","journal-title":"Biochemistry And Biophysics."},{"key":"2026073102125945300_cit41","doi-asserted-by":"publisher","first-page":"554","DOI":"10.3390\/pharmaceutics12060554","article-title":"Microscale Thermophoresis as a Screening\nTool to Predict Melanin Binding of Drugs","volume":"12","author":"Hellinen","year":"2020","journal-title":"Pharmaceutics"},{"key":"2026073102125945300_cit42","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.202400601","article-title":"Lasamide\nContaining Sulfonylpiperazines as Effective Agents for the Management\nof Glaucoma Associated Symptoms","author":"Kilbile","year":"2024","journal-title":"Chem. Med.\nChem."},{"issue":"11","key":"2026073102125945300_cit43","first-page":"2756","article-title":"Optic nerve oxygen tension in pigs and the effects\nof carbonic anhydrase inhibitors","volume":"40","author":"Stefa\u0301nsson","year":"1999","journal-title":"Invest. Ophthalm.\nVis. Sci."},{"issue":"2","key":"2026073102125945300_cit44","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.exer.2003.11.010","article-title":"Dorzolamide\nInduces Vasodilatation in Isolated pre-contracted Bovine Retinal Arteries","volume":"78","author":"Josefsson","year":"2004","journal-title":"Exp. Eye Res."},{"key":"2026073102125945300_cit45","doi-asserted-by":"publisher","first-page":"467","DOI":"10.3390\/ijms20030467","article-title":"Carbonic Anhydrase\nInhibitors of Different Structures Dilate Pre-Contracted Porcine Retinal\nArteries","volume":"20","author":"Eysteinsson","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"2026073102125945300_cit46","doi-asserted-by":"publisher","first-page":"8140","DOI":"10.3390\/ijms24098140","article-title":"Membrane Permeability is required for the vasodilatory\neffect of Carbonic Anhydrase Inhibitors in porcine retinal arteries","volume":"24","author":"Eysteinsson","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"2026073102125945300_cit47","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s00210-010-0526-5","article-title":"Pharmacological Evidence for the\nPresence of functional \u03b23 Receptors in Rat retinal Blood Vessels","volume":"382","author":"Mori","year":"2010","journal-title":"naunyn-Schmied Arch Pharmacol."},{"key":"2026073102125945300_cit48","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s00210-017-1349-4","article-title":"Stimulation of \u03b21- and \u03b22-Adrenoceptors\nDilates Retinal Blood Vessels in Rats","volume":"390","author":"Mori","year":"2017","journal-title":"naunyn-Schmied\nArch Pharmacol."},{"key":"2026073102125945300_cit49","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1124\/jpet.119.256933","article-title":"Ocular Drug\nDelivery: Present Innovations and Future Challenges","volume":"370","author":"Gote","year":"2019","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"2026073102125945300_cit50","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.addr.2017.12.008","article-title":"Implications of\nmelanin binding in ocular drug delivery","volume":"126","author":"Rimpela\u0308","year":"2018","journal-title":"Adv.\nDrug Delivery Rev."},{"key":"2026073102125945300_cit51","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1038\/s41467-023-38056-w","article-title":"Machine learning-driven\nmultifunctional peptide engineering for sustained ocular drug delivery","volume":"14","author":"Hsueh","year":"2023","journal-title":"Nat. Commun."},{"key":"2026073102125945300_cit52","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1021\/acs.molpharmaceut.4c00694","article-title":"Melanin-Binding-Based Discovery of Topically Instilled Carbonic Anhydrase\nInhibitors for Targeted Delivery and Prolonged Action in the Eye","volume":"22","author":"Valtari","year":"2025","journal-title":"Mol. Pharm."},{"key":"2026073102125945300_cit53","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1167\/iovs.65.12.14","article-title":"Comprehensive Pharmacokinetic Evaluation of High Melanin Binder Levofloxacin\nin Rabbits Shows Potential of Topical Eye Drops for Posterior Segment\nTreatment","volume":"65","author":"Bahrpeyma","year":"2024","journal-title":"Invest. Ophthalmol. Visual Sci."},{"key":"2026073102125945300_cit54","doi-asserted-by":"publisher","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","article-title":"Relationship between the inhibition constant (K1) and\nthe concentration of inhibitor which causes 50% inhibition (I50) of\nan enzymatic reaction","volume":"22","author":"Cheng","year":"1973","journal-title":"Biochem. Pharmacol."},{"key":"2026073102125945300_cit55","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1080\/14756366.2016.1177525","article-title":"Lansoprazole and carbonic anhydrase IX inhibitors sinergize against\nhuman melanoma cells","volume":"31","author":"Federici","year":"2016","journal-title":"J. Enzyme Inhib. Med.\nChem."},{"key":"2026073102125945300_cit56","doi-asserted-by":"publisher","first-page":"4681","DOI":"10.1016\/j.bmcl.2012.05.083","article-title":"Ureido-substituted sulfamates show\npotent carbonic anhydrase IX inhibitory and antiproliferative activities\nagainst breast cancer cell lines","volume":"22","author":"Winum","year":"2012","journal-title":"Bioorg. Med.\nChem. Lett."},{"key":"2026073102125945300_cit57","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1126\/science.1067308","article-title":"Requirement of the activation-induced deaminase (AID)\ngene for immunoglobulin gene conversion","volume":"295","author":"Arakawa","year":"2002","journal-title":"Science"},{"key":"2026073102125945300_cit58","doi-asserted-by":"publisher","first-page":"2270","DOI":"10.3390\/pharmaceutics14112270","article-title":"Mouse Pharmacokinetics\nand In Vitro Metabolism of SH-11037 and SH-11008, Synthetic Homoisoflavonoids\nfor Retinal Neovascularization","volume":"14","author":"Kim","year":"2022","journal-title":"Pharmaceutics"},{"key":"2026073102125945300_cit59","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/S0039-6257(01)00211-9","article-title":"The Draize eye test","volume":"45","author":"Wilhelmus","year":"2001","journal-title":"Surv. Ophthalmol."},{"key":"2026073102125945300_cit60","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1021\/acs.jmedchem.1c01906","article-title":"One-Pot Procedure for the Synthesis of Asymmetric Substituted Ureido\nBenzene Sulfonamides as Effective Inhibitors of Carbonic Anhydrase\nEnzymes","volume":"65","author":"Vannozzi","year":"2022","journal-title":"J. Med. Chem."},{"key":"2026073102125945300_cit61","doi-asserted-by":"publisher","first-page":"981","DOI":"10.3390\/ijms20040981","article-title":"Role of Histamine\nH3 Receptor Antagonists on Intraocular Pressure Reduction\nin Rabbit Models of Transient Ocular Hypertension and Glaucoma","volume":"4","author":"Lanzi","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"2026073102125945300_cit62","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0160352","article-title":"Isolation of Intact\nand Functional Melanosomes from the Retinal Pigment Epithelium","volume":"11","author":"Pelkonen","year":"2016","journal-title":"PLoS One"},{"key":"2026073102125945300_cit63","doi-asserted-by":"publisher","first-page":"13761","DOI":"10.1038\/s41598-019-50324-8","article-title":"Characterization of artificially re-pigmented ARPE-19\nretinal pigment epithelial cell model","volume":"9","author":"Hellinen","year":"2019","journal-title":"Sci.\nRep."}],"container-title":["Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.jmedchem.5c01459","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article-pdf\/68\/17\/18579\/66294911\/acs.jmedchem.5c01459.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article-pdf\/68\/17\/18579\/66294911\/acs.jmedchem.5c01459.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T06:13:05Z","timestamp":1785478385000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article\/68\/17\/18579\/5234791\/Repurposing-Drug-Metabolites-into-Dual-Adrenergic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,26]]},"references-count":63,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2025,8,26]]},"published-print":{"date-parts":[[2025,9,11]]}},"URL":"https:\/\/doi.org\/10.1021\/acs.jmedchem.5c01459","relation":{},"ISSN":["0022-2623","1520-4804"],"issn-type":[{"value":"0022-2623","type":"print"},{"value":"1520-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,26]]}}}